Zhitong Finance App News, Sanli Pharmaceutical (603439.SH) announced that the company (Party A) recently signed a “Technology Transfer (Patent Application) Contract” (hereinafter referred to as the “Technology Transfer Contract”) with Hainan University (Party B). This school-enterprise cooperation aims to achieve resource sharing and complementary advantages between schools and enterprises through strengthened exchanges and cooperation, promote the transformation of innovative drug research achievements by integrating the company's industrialization capabilities and university R&D resources, help the company expand the layout of innovative drug products, and enhance the company's competitive advantage in the market.
Party B transfers the right to apply for the HXW2324 compound and related patents to Party A, and Party A accepts and pays the corresponding transfer price. At the same time, Party B shall submit to Party A all patent application documents submitted to the Chinese Patent Office and all documents issued to Party B by the China Patent Office. The total transfer price of the invention patent right or patent application right agreed in the contract is RMB 200 million, including the milestone payment of RMB 0.2 billion (tax included) and sales commission of RMB 180 million (tax included). The transfer price shall be paid by Party A in installments to Party B as agreed in the contract. Among them, the first milestone payment conditions: Party B carried out a pharmacodynamic study of the HXW2324 compound on three classic animal models of Alzheimer's disease after signing this contract; after the study results were determined by both parties to have anti-Alzheimer's efficacy and the two parties agreed to continue the follow-up study, Party A paid Party 3 million yuan in full.
After the HXW2324 compound (formulation) is sold, Party A pays Party B a commission fee of 2 yuan (including VAT) per box according to the variety agreed in the contract. The settlement period is annual settlement. The total sales commission reaches 180 million yuan (tax included) or five years after the initial withdrawal of sales commissions. Party A is no longer required to provide sales commission to Party B.